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We report a case of complete hydatidiform mole in a 54-year-old patient referred to Gynecology department of General Hos-
pital of Athens “Laiko”, with history of previous molar pregnancy at the age of thirty-six. Our purpose was to indicate the ad-
vanced maternal age beside the long recurrence distance of the disease, which was eighteen years after the ﬁrst molar preg-
nancy. Our diagnostic approach was through measurement of serum beta-human chorionic gonadotropin (β-HCG) and pelvic
ultrasound evaluation, and the chosen therapeutic approach was abdominal hysterectomy and bilateral salpingoophorecto-
my.
1.Introduction
Hydatidiform moles (HMs) essentially represent an abnor-
mality of placental development as a consequence of over-
expression of paternally derived genes and are therefore
examples of abnormalities ofimprinting. Theyare associated
with structural placental abnormalities and fetal develop-
mental defects and are characterized pathologically from
nonmolar pregnancies by the presence of abnormal tro-
phoblasthyperplasia.Theyaresimplydividedintotwomajor
subtypes, complete (CHM) and partial (PHM) hydatidi-
form mole, according to pathologic and genetic features [1–
3].
Studies from the United States and England have found
that women with a history of one molar pregnancy (partial,
complete, or persistent GTN) have an approximately 1%
chance of recurrence in subsequent pregnancy (compared
to a 0.1% incidence in the general population of the United
States) [4–6] .T h er e c u r r e n c er a t ei sm u c hh i g h e ra f t e rt w o
molar pregnancies (16 to 18%) [7–10].
2.DescriptionofCase
A 54-year-old patient, gravida 3, para 2, was referred to Gen-
eral Hospital of Athens, “Laiko” with intermittent, irregular
vaginalbleedingforthelastthreemonthsandaconcomitant,
mild abdominal pain.
The patient is a mother of two children, full-term cesare-
an deliveries. Last delivery was twenty years ago (at the age of
34).Two yearslater(age36),she developedacompletemolar
pregnancy which was, at that time, managed with evacuation
of the uterine contents by suction and curettage.
The patient arrived inourdepartment complaining from
irregular menstrual period in the last year, with an interval
of three months of amenorrhea. She had never used any
contraceptive method and was average in weight, of medium
socioeconomic status, and with no history of hypertension,
diabetes, or symptoms of thyroid disease.
A thorough clinical history was taken. Physical exam-
ination, blood pressure, chest rays, and electrocardiogram
were normal, abdominal and pelvic examination revealed2 Case Reports in Medicine
enlargement of the uterus reaching about 17-week gestation,
and speculum and bimanual examination demonstrated a
healthy cervix with slight uterine bleeding.
Ultrasound evaluationshowed a uterinecavityﬁlled with
central heterogeneous mass with anechoic spaces of varying
size and shape. Moreover a subserous ﬁbroid was found at
the fundus with a size of 2 × 3cm(Figure 1).
Maternalserum beta-chorionicgonadotrophin(β-HCG)
levels were 97000IU/L. She was admitted to hospital for pre-
operative assessment. Blood group and Rh factor, matching
of two units of compatible blood, were prepared.
Diﬀerential diagnosis included (apart molar pregnancy
and choriocarcinoma) germ cell tumors and other malig-
nancy involving organs like the ovary, bladder, uterus, lung,
liver, pancreas and stomach neoplasms, although β-HCG’s
relatively high levels turn away from these [11]. Considering
the patient’s age and with her concordant opinion, a laparo-
tomy and hysterectomy with bilateral salpingo-oophorec-
tomy (H.B.S.O.)were decided.
Histopathology showed a complete mole with no evi-
dence of invasion, and chromosomal analysis revealed pater-
nal origin (46,XX).
Followup after two and four weeks of operation with se-
rum β-HCG measurements showed that the level returned
back to normal. The patient was followed for the next six
months with β-HCG which did not show any abnormal-
ity.
3.Discussion
Hydatidiform mole is a gestational trophoblastic disorder
due to abnormal gametogenesis and fertilization. There are
two types of hydatidiform mole, namely, complete and par-
tial. Its incidence increases at the extremes of reproductive
age. Teenagers and perimenauposal women are most at risk
[12]. Characteristically, women older than 35 years of age
have a relative risk of 2.0, and women over 40 years of age
have a 5- to 10-fold increase [13]. However a single study
statesthatrepetitionofthedisease(secondmolarpregnancy)
seems to present within 2 to 4 years after the ﬁrst incident
(patients in the study were followed up for one year if partial
mole was the diagnosis and for 2 years if complete mole was
observed) [5]. Case reports in extreme cases of patients with
multiple recurrences of molar pregnancies conﬁrm these
ﬁndings [14, 15].
Complete hydatidiform mole (CHM) results from the
fertilization of an egg, from which the nuclear material has
been lost or inactivated by a single sperm having 23,XX
chromosomes which duplicates to 46,XX. This makes com-
plete mole homozygous, female, and androgenic in origin
[16]. Less frequently, fertilization occurs with two sperms
resulting in either 46xx or 46xy heterozygous chromosomal
constitution[17]. Biparental CHMs are reported in a limited
number of studies and seem to be extremely rare [18, 19].
However, a study by Moglabey et al. in which several sisters
had one or more CHM, it was found that all of them were
biparental in origin, implying that familial repetitive HM is
of biparental origin.
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Figure 1: Explanatory legend: Transvaginal ultrasound of the pa-
tient. Snowstorm-like appearance. Uterus dimension: 94,87mm ×
125,67mm.
Inpartial hydatidiform mole,maternal chromosomesare
present and the condition arises by diandry (one maternal
and two paternal sets of chromosomes) [20].
The genetic background of mole is a matter of investi-
gation in several studies. Genes implicated in familial forms
and repetitive case reports are the NLRP7 and C6orf221 [21,
22]. Researchers found that NLRP7 mutations at 19q13.4
were responsible for an increase in stochastic and mosaic
aneuplodies during early embryo development [23]. Even-
tually, the resulting embryos survived through implantation
or regressed and diseased, depending on their severity. The
pathogenetic pathway between mutations of the NLRP7
gene and the development of molar pregnancy is explained
throughaninabilitytoexpressinﬂammatory responsetovar-
ious antigens and stimuli [23]. The NLRP genes (Nucleotide-
binding oligomerization domain, Leucine rich Repeat, and
Pyrin domain containing Proteins) seem to be interrelated
with the mammalian reproductive system [24]. Further
investigation of NLRP7’s structural polymorphisms may
highlight its participation in the pathogenesis of hydatiform
mole, rendering it a possible prenatal marker in the future.
Both forms of moles are potentially malignant. The risk
of gestational trophoblastic neoplasia for partial mole is <5–
10%andthatofcompletemoleis20%.Theriskofrecurrence
of hydatidiform mole is 0.5–2.8% with a subsequent greater
risk of developing invasive mole or choriocarcinoma [10].
The risk of repeat hydatidiform mole in next pregnancy is
1:76,whiletheriskaftertwopasthydatidiformmoleis1:6.5
[6].
Molar pregnancy is an uncommon cause of abdominal
pain and vaginal bleeding. In a retrospective case study, the
authors stated abdominal pain with enlarged uterine size in
54% of women with mole and vaginal bleeding in another
75%.
Inpatientswith a second molar pregnancy, the patholog-
ical type is not necessarily of the same type. Of women with
a complete molar pregnancy who have another molar preg-
nancy, 81% had another CHM, whilst 19% had a PHM withCase Reports in Medicine 3
their next molar pregnancy. Similarly, of those who had a
PHM for their ﬁrst molar pregnancy and then went on to
have another molar pregnancy, 68% had another PHM and
32% a CHM [25].
Literature often reports recurrence or repetition of the
disease, but this usually happens in a short period of time
[26]. We could not detect in literature cases that recurred
after 5 years of ﬁrst disease, so we consider that the case we
report is fairly rare and interesting, since the recurrence oc-
curred 18 years after the ﬁrst event.
4.Conclusion
Complete hydatiform mole is a disease that may recur at any
timeline after the ﬁrst incident. Although most cases are
described as having short intervals of time and usually of
the same histological type, this is not an unbreakable rule.
Women in the 6th decade of life usually present with vaginal
bleeding as a result of menstrual abnormalities resulting
from induction to menopause. Endometrial polyps, endo-
metrial hyperplasia, and endometrial cancer are other pos-
sible causes of vaginal bleeding. However, when levels of β-
HCG are high, molar pregnancy is the most possible diagno-
sis, as its incidence increases at ages <20 years and >40 years.
Abbreviations
HM: Hydatidiform mole
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